William R. Sellers

William Sellers leads the Cancer Program at the Broad Institute, driving large-scale functional genomics efforts to identify cancer vulnerabilities. His research has characterized synthetic lethal interactions and developed CRISPR-based screening platforms for therapeutic target discovery. Previously, he led oncology research at Novartis.

William Sellers领导布罗德研究所的癌症项目，推动大规模功能基因组学工作以识别癌症脆弱性。他的研究描述了合成致死相互作用，并开发了用于治疗靶点发现的基于CRISPR的筛选平台。此前，他曾在诺华领导肿瘤学研究。